Nuclear alteration | Dry | Rainy | ||||
---|---|---|---|---|---|---|
Site 2 | Site 3 | Reference | Site 2 | Site 3 | Reference | |
Erythrocytes (x106x µl-1) | 2.06 ± 0.09 | 2.09 ± 0.10 | 2.38 ± 0.13 | 1.58 ± 0.09* | 1.80 ± 0.12* | 2.26 ± 0.15 |
Leukocytes (x103x µl-1) | 71.65 ± 6.71 | 74.25 ± 5.95 | 60.11 ± 5.46 | 40.09 ± 1.35 | 56.56 ± 1.85 | 32.32 ± 1.62 |
Thrombocytes (x103x µl-1) | 70.10 ± 9.04 | 51.24 ± 4.67 | 57.36 ± 6.96 | 33.59 ± 1.33 | 52.75 ± 2.23* | 26.73 ± 0.88 |
Hemoglobin (g/dl) | 7.82 ± 0.31* | 7.47 ± 0.32* | 10.03 ± 0.27 | 8.55 ± 0.18 | 8.15 ± 0.08 | 8.61 ± 0.51 |
PVC (%) | 21.0 ± 0.68 | 19.26 ± 0.79* | 23.63 ± 0.94 | 23.57 ± 0.85 | 21.60 ± 0.46* | 26.0 ± 0.98 |
MCV (fL) | 107.38 ± 5.33 | 105.90 ± 8.40 | 105.04 ± 8.21 | 153.80 ± 4.01 | 138.20 ± 7.0 | 119.73 ± 5.79 |
MCH (pg) | 41.03 ± 2.75 | 41.68 ± 3.53 | 44.33 ± 2.93 | 59.18 ± 3.60* | 55.09 ± 3.85* | 35.56 ± 5.46 |
MCHC (%) | 37.70 ± 1.42 | 40.14 ± 1.78 | 43.0 ± 1.34 | 37.91 ± 1.78* | 38.63 ± 1.10* | 28.30 ± 2.97 |
Lymphocytes (%) | 63.27 ± 0.50* | 56.62 ± 0.50* | 75.38 ± 1.05 | 63.18 ± 0.53* | 64.93 ± 1.57* | 73.93 ± 1.08 |
Neutrophils (%) | 29.30 ± 0.84* | 32.41 ± 0.74* | 23.75 ± 0.90 | 28.75 ± 1.05* | 28.98 ± 0.96* | 23.0 ± 0.95 |
Monocytes (%) | 3.03 ± 0.28 | 2.51 ± 0.16 | 2.38 ± 0.29 | 3.46 ± 0.31 | 2.98 ± 0.16 | 2.79 ± 0.32 |
Basophils (%) | 0.55 ± 0.09 | 0.59 ± 0.08 | 0.44 ± 0.13 | 0.57 ± 0.10 | 0.40 ± 0.08 | 0.64 ± 0.13 |
Eosinophils (%) | 0 ± 0 | 0 ± 0 | 0.38 ± 0.13 | 0 ± 0 | 0.30 ± 0.07 | 0.36 ± 0.13 |